Who
Benjamin Cravatt
Director
Company insider
Files Form 4 as: Director, Alnylam Pharmaceuticals; Director, Kyntra Bio.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $68K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 5 Aug 2020
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | ALNY Alnylam Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,393 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | ALNY Alnylam Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,393 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 9 Jun 2023filed 9 Jun 2023 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Sold | $30K1,766 at $16.75 | filing |
| 9 Jun 2023filed 9 Jun 2023 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Sold | $38K2,178 at $17.51 | filing |
| 7 Jun 2023filed 9 Jun 2023 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —12,666 at $0.00 | filing |
| 7 Jun 2023filed 9 Jun 2023 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code A | —8,289 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —25,684 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code A | —15,777 at $0.00 | filing |
| 26 May 2021filed 28 May 2021 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code A | —4,700 at $0.00 | filing |
| 26 May 2021filed 28 May 2021 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
| 5 Aug 2020filed 7 Aug 2020 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —6,496 at $0.00 | filing |
| 5 Aug 2020filed 7 Aug 2020 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —10,400 at $0.00 | filing |
| 5 Aug 2020filed 7 Aug 2020 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Code A | —3,914 at $0.00 | filing |
News
Kyntra Bio (KYNB): Can Its New Strategy And Pipeline Revive Investor Interest?KYNB · rttnews.com · 19 Oct 2026Kyntra Bio Inc (KYNB) – What Are Brokerages Saying About This Stock?KYNB · dailypolitical.com · 14 Oct 2026Prothena (NASDAQ:PRTA) vs. Kyntra Bio (NASDAQ:KYNB) Financial ReviewKYNB · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name Benjamin Cravatt; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.